Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may trigger sudden temporary hair loss.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

COVID-19 infection and vaccination may trigger hair loss and rapid hair whitening.

Cannabis has anti-inflammatory and antimicrobial properties, but more research is needed on its effects on plant and aquatic animal pathogens.

The XBB lineage of the Omicron variant spread rapidly in Southeastern Wisconsin.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Beau's lines on nails may indicate severe COVID-19 or vaccination response.

Standardized tools and treatments are needed to better manage long COVID-19 in kids and teens.

Long COVID is a big health problem needing more research and better treatments.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Women are more likely to have long-term post-COVID symptoms than men.

Allogenic ASCs and ECM transplants are safe and effective for tissue regeneration.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

Proper mTOR signaling is crucial for healthy skin and preventing skin diseases.

Enhancing antioxidant responses can improve treatments for various diseases.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Engineered extracellular vesicles could improve CRISPR/Cas delivery, making gene editing safer and more effective.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.